Chromophobe Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Chromophobe Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study [Phase 2]
Phase 2 trial exploring the addition of radium-223 dichloride to cabozantinib for advanced renal cell carcinoma with bone metastases (RadiCa…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
A Mayo Clinic-led clinical trial is evaluating whether tumor-derived extracellular vesicles can noninvasively classify different kidney canc…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma [EARLY_Phase 1]
This early-phase trial is evaluating memory-like natural killer (NK) cell therapy in patients with renal cell carcinoma and urothelial carci…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy [NA]
This is an update on a clinical research study (NCT04623502) investigating kidney and urothelial tumor metabolism in patients undergoing sur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC [Phase 2]
Phase 2 clinical trial update evaluating cabozantinib in combination with nivolumab and ipilimumab for advanced non-clear cell renal cell ca…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating cabozantinib or sunitinib malate in patients with metastatic variant histology renal cell carcinoma, inclu…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
A Mayo Clinic-led INQUIRE study is identifying novel high-quality methylated DNA markers for renal tumors. The project uses whole-methylome …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit [Phase 1]
Phase 1 study evaluating NN3201, a c-Kit targeted antibody-drug conjugate, in advanced and/or metastatic solid tumors expressing c-Kit; curr…